Aptiv price target raised to $90 from $85 at JPMorgan

JPMorgan raised the firm’s price target on Aptiv (APTV) to $90 from $85 and keeps an Overweight rating on the shares. The company reported solid Q2 results and reinstated full year guidance at a level above the Street, the analyst tells investors in a research note.